Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Inxo A/S
A/S
Bankrupt
Advertising protection
CVR 37758272
Høstvej 4C, 2800
Kongens Lyngby
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2016 · 10 years old
1 employees
www.xoyourlife.com
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Inxo A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (2)
PC
Pouline Charlotte Friderichsen Middleton
Chief Executive Officer
Chief Executive Officer
2021 – 2025
JA
Jahangir Ashraf Khan
Chief Executive Officer
Chief Executive Officer
2016 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Former (10)
CW
Cathrine Werthwein Andersen
Board of Directors
Board of Directors
2021 – 2022
EC
Emilia Caparros van Hauen
Board of Directors
Board of Directors
2022 – 2025
CG
Carsten Gram Andersen
Board of Directors
Board of Directors
2023 – 2025
MB
Mikkel Bender
Chairman
Chairman
2025 – 2025
NC
Niels Christian Nielsen
Chairman
Chairman
2020 – 2025
MC
Mikal Christian Hallstrup
Board of Directors
Board of Directors
2020 – 2022
BS
Brian Sussemiehl
Board of Directors
Board of Directors
2020 – 2022
PJ
Paul James Greenall
Board of Directors
Board of Directors
2022 – 2025
KI
Katja Iversen
Board of Directors
Board of Directors
2022 – 2025
RS
Rasmus Schmiegelow
Chairman
Chairman
2016 – 2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Niox Holding ApS
Company
25–33.32%
25–33.32%
2023
COPAseed A/S
Company
15–19.99%
15–19.99%
2020
MEVA HOLDING ApS
Company
10–14.99%
10–14.99%
2023
H.ApS
Company
5–9.99%
5–9.99%
2022
SPINAL ApS
Company
5–9.99%
5–9.99%
2022
Susmil Holding ApS
Company
5–9.99%
5–9.99%
2022
NCN Advise & Invest ApS
Company
5–9.99%
5–9.99%
2020
BRAINWASH MUSIC NETWORK ApS
Company
0%
5–9.99%
2018
ECHOSTAR HOLDING ApS
Company
0%
5–9.99%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Inxo A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network